Reset
Id
Protein
PTM type
Site
Species
Disease
Cell line
Drug
Regulatory
Confidence score(level)
Ref.
acc1501 ERK2 phosphorylation Tyr187 human Pancreas Cancer MIA PaCa-2 SN-38 + Axitinib Associated 4.0 (Moderate) 21390185
acc1502 AKT phosphorylation Thr308 human Pancreas Cancer Capan-1 SN-38 + Axitinib Associated 4.0 (Moderate) 21390185
acc1503 AKT phosphorylation Thr308 human Pancreas Cancer MIA PaCa-2 SN-38 + Axitinib Associated 4.0 (Moderate) 21390185
acc1504 AKT phosphorylation Thr308 human Pancreas Cancer Capan-1 SN-38 Associated 4.0 (Moderate) 21390185
acc1505 AKT phosphorylation Thr308 human Pancreas Cancer MIA PaCa-2 SN-38 Associated 4.0 (Moderate) 21390185
acc1506 AKT phosphorylation Thr308 human Pancreas Cancer Capan-1 Axitinib Associated 4.0 (Moderate) 21390185
acc1507 AKT phosphorylation Thr308 human Pancreas Cancer MIA PaCa-2 Axitinib Associated 4.0 (Moderate) 21390185
acc1508 ErbB3 phosphorylation unclear human Breast Cancer MDA-MB-453 SNDX-275 + Trastuzumab Associated 4.0 (Moderate) 21497990
acc1509 ErbB3 phosphorylation unclear human Breast Cancer BT474 SNDX-275 + Trastuzumab Associated 4.0 (Moderate) 21497990
acc1510 Akt phosphorylation unclear mouse Hepatocellular Carcinoma NK92-MI Sorafenib Associated 4.0 (Moderate) 23409093
acc1511 ERK phosphorylation unclear human Bladder Cancer T24 Sorafenib Associated 4.0 (Moderate) 20649572
acc1512 ERK phosphorylation unclear human Bladder Cancer J82 Sorafenib Associated 4.0 (Moderate) 20649572
acc1513 ERK phosphorylation unclear human Bladder Cancer RT4 Sorafenib Associated 4.0 (Moderate) 20649572
acc1514 FKHR phosphorylation Ser256 human Lung Cancer GLC-82 SYUNZ-16 Associated 4.0 (Moderate) 19904742
acc1515 FKHRL1 phosphorylation Ser318 human Lung Cancer GLC-82 SYUNZ-16 Associated 4.0 (Moderate) 19904742
acc1516 FKHRL1 phosphorylation Ser321 human Lung Cancer GLC-82 SYUNZ-16 Associated 4.0 (Moderate) 19904742
acc1517 FKHR phosphorylation Ser256 human Hepatocellular Carcinoma Hep3B SYUNZ-16 Associated 4.0 (Moderate) 19904742
acc1518 FKHRL1 phosphorylation Ser318 human Hepatocellular Carcinoma Hep3B SYUNZ-16 Associated 4.0 (Moderate) 19904742
acc1519 FKHRL1 phosphorylation Ser321 human Hepatocellular Carcinoma Hep3B SYUNZ-16 Associated 4.0 (Moderate) 19904742
acc1520 bcl-2 phosphorylation Ser70 human Breast Cancer MCF-18 Docetaxel Associated 4.0 (Moderate) 12576925
acc1521 Bcl-2 phosphorylation Ser70 human Prostate Cancer Taxol Associated 4.0 (Moderate) 8640809
acc1522 STAT3 phosphorylation Tyr705 human Gastric Cancer MKN45 HP590 Associated 4.0 (Moderate) 36103247
acc1523 STAT3 phosphorylation Ser727 human Gastric Cancer MKN45 HP590 Associated 4.0 (Moderate) 36103247
acc1524 STAT3 phosphorylation Tyr705 human Gastric Cancer AGS HP590 Associated 4.0 (Moderate) 36103247
acc1525 STAT3 phosphorylation Ser727 human Gastric Cancer AGS HP590 Associated 4.0 (Moderate) 36103247
acc1526 STAT3 phosphorylation Tyr705 human Gastric Cancer MGC803 HP590 Associated 4.0 (Moderate) 36103247
acc1527 STAT3 phosphorylation Ser727 human Gastric Cancer MGC803 HP590 Associated 4.0 (Moderate) 36103247
acc1528 USP8 phosphorylation Thr907 human Breast Cancer MCF7 NRG1 OV Associated 3.0 (Low) 17210635
acc1529 ErbB3 ubiquitination unclear human Breast Cancer MCF7 NRG1 OV Associated 3.0 (Low) 17210635
acc1530 ASK-1 phosphorylation Thr845 human Glioma U87 Temozolomide Enhancing 5.0 (High) 36951032
acc1531 ASK-1 phosphorylation Thr845 human Glioma U251 Temozolomide Enhancing 5.0 (High) 36951032
acc1532 ERK1 phosphorylation Thr202 human Breast Cancer BT474 anti-HER2 phage-based vaccine Associated 3.0 (Low) 36011047
acc1533 ERK1 phosphorylation Tyr204 human Breast Cancer BT474 anti-HER2 phage-based vaccine Associated 3.0 (Low) 36011047
acc1534 ERK2 phosphorylation Thr185 human Breast Cancer BT474 anti-HER2 phage-based vaccine Associated 3.0 (Low) 36011047
acc1535 ERK2 phosphorylation Tyr187 human Breast Cancer BT474 anti-HER2 phage-based vaccine Associated 3.0 (Low) 36011047
acc1536 HSP27 phosphorylation Ser15 human Breast Cancer JIMT-1 TZMB Impairing 5.0 (High) 32545363
acc1537 HSP27 phosphorylation Ser78 human Breast Cancer JIMT-1 TZMB Impairing 5.0 (High) 32545363
acc1538 PDGFRB phosphorylation Tyr751 human Glioblastoma A172 EGCG Associated 4.0 (Moderate) 10198059
acc1539 PDGFRB phosphorylation Tyr751 mouse Glioblastoma NIH 3T3 EGCG Associated 4.0 (Moderate) 10198059
acc1540 Cdc25C phosphorylation Ser216 human Lung Cancer A549 LBH589 Associated 4.0 (Moderate) 21179472
acc1541 cdc2 phosphorylation Tyr15 human Lung Cancer A549 LBH589 Associated 4.0 (Moderate) 21179472
acc1542 Cdc25C phosphorylation Ser216 human Lung Cancer A549 Scriptaid Associated 4.0 (Moderate) 21179472
acc1543 cdc2 phosphorylation Tyr15 human Lung Cancer A549 Scriptaid Associated 4.0 (Moderate) 21179472
acc1544 Cdc25C phosphorylation Ser216 human Lung Cancer PC9 LBH589 Associated 4.0 (Moderate) 21179472
acc1545 cdc2 phosphorylation Tyr15 human Lung Cancer PC9 LBH589 Associated 4.0 (Moderate) 21179472
acc1546 Cdc25C phosphorylation Ser216 human Lung Cancer PC9 Scriptaid Associated 4.0 (Moderate) 21179472
acc1547 cdc2 phosphorylation Tyr15 human Lung Cancer PC9 Scriptaid Associated 4.0 (Moderate) 21179472
acc1548 ERK1 phosphorylation Thr202 human Sarcoma SA-4 Vemurafenib Associated 4.0 (Moderate) 29570692
acc1549 ERK1 phosphorylation Tyr204 human Sarcoma SA-4 Vemurafenib Associated 4.0 (Moderate) 29570692
acc1550 ERK2 phosphorylation Thr185 human Sarcoma SA-4 Vemurafenib Associated 4.0 (Moderate) 29570692